Table 3.
Study | N | Participants | Age (range) | Education (years, range) | Time post stroke (range) | Imaging modality |
---|---|---|---|---|---|---|
ACUTE STROKE | ||||||
Wright et al. (2018) | 4 | RHD (3), FTD | 56–61 | 1 RHD: 16+ | RHD: 1/3 <48 hours, 2/3 nr; FTD: dx 1 year prior to testing | MRI |
Starkstein et al.(1994) | 76 | RHD & LHD (59), NBD | LHD & RHD: No
aprosodia: M = 52.3; Mild aprosodia: M = 59.9; Severe aprosodia: M = 60.9 (range nr); NBD: 33–62 |
LHD & RHD: No
aprosodia: M = 11.3; Mild aprosodia: M = 8.6; Severe aprosodia: M = 10.0 (range nr); NBD: nr |
RHD & LHD: No aprosodia: M = 6.1 days; Mild aprosodia: M = 5.9 days; Severe aprosodia: M = 7.2 days (range nr) |
CT |
Patel et al. (2018) | 41 | RHD | M = 62.7 (range nr) | M = 14.4 (range nr) | <48 hours | MRI |
Sheppard et al. (2020) | 33 | RHD (23), NBD | RHD M = 55.09; NBD M = 53.33 (range nr) | nr | <5 days; 9/23 RHD retested at 6+ months | MRI |
SUBACUTE/CHRONIC STROKE | ||||||
Ross (1981) | 10 | RHD | 34–76 | nr | < 24hrs-5 months | CT |
Gorelick & Ross (1987) | 14 | RHD | 36–82 | nr | 0.5–2 months | CT |
Hughes et al. (1983) | 19 | RHD (12), NBD | 32–70 | 0–16 | 0.4–27 months | CT |
Baum & Pell (1997) | 21 | LHD (4), RHD (7), NBD | 43–85 | nr | 9–76 months | nr |
Ross & Monnot (2008) | 82 | RHD (21), LHD (18), NBD | 43–78 | 8–17 | 3–8 weeks | MRI |
Darby (1993) | 84 | RHD (26), LHD (16), ns lacunar infarcts (31), NBD |
57–86 (aprosodia subset) | nr | Time 1: 2–3 days; Time 2: 14107 days (aprosodia subset) | CT |
Cancelliere & Kertesz (1990) | 66 | RHD (28), LHD (18) | RHD & LHD: M = 62.5; NBD: M = 62.4 (range nr) | nr | M = 25.6 days (range nr) | CT |
Note. LHD = Left Hemisphere Brain Damage; RHD = Right Hemisphere Brain Damage; NBDs = Controls without Brain Damage; FTD = Frontotemporal Dementia; M = Mean; nr = Not Reported; dx = Diagnosis; ns = Not specified